Back to Insider Trading View Full Company Profile

ACLX

STRONG

Arcellx, Inc.

CIK: 0001786205

Strong Sell (90% confidence)

Last activity: Feb 27, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Total Cash $254.80M
Current Ratio 8.15

Insider Roster (4 total, 4 active)

Insider Buys Sells Net Value Holdings
Elghandour Rami
SEE REMARKS
0 1 -$10.24M
276,051 shares
$31.45M
Gilson Michelle
CHIEF FINANCIAL OFFICER
0 6 -$2.63M
33,938 shares
$3.86M
Heery Christopher
CHIEF MEDICAL OFFICER
0 3 -$1.28M
23,749 shares
$1.63M
Lubner David Charles
OTHER
0 1 -$450K
21,659 shares
$1.62M

Recent Transactions

SELL Elghandour Rami (SEE REMARKS)

89,916 shares @ $113.92

$10.24M

Feb 27, 2026

Conviction: | View SEC Filing →
SELL Gilson Michelle (CHIEF FINANCIAL OFFICER)

11,219 shares @ $113.82

$1.28M

Feb 25, 2026

Conviction: | View SEC Filing →
SELL Gilson Michelle (CHIEF FINANCIAL OFFICER)

5,405 shares @ $68.57

$371K

Feb 19, 2026

Conviction: | View SEC Filing →
SELL Gilson Michelle (CHIEF FINANCIAL OFFICER)

2,879 shares @ $67.73

$195K

Feb 19, 2026

Conviction: | View SEC Filing →
SELL Gilson Michelle (CHIEF FINANCIAL OFFICER)

100 shares @ $69.38

$7K

Feb 19, 2026

Conviction: | View SEC Filing →
SELL Gilson Michelle (CHIEF FINANCIAL OFFICER)

7,141 shares @ $69.21

$494K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Gilson Michelle (CHIEF FINANCIAL OFFICER)

4,150 shares @ $70.01

$291K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Lubner David Charles (OTHER)

6,000 shares @ $75.00

$450K

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Heery Christopher (CHIEF MEDICAL OFFICER)

5,882 shares @ $68.51

$403K

Jan 14, 2026

Conviction: | View SEC Filing →
SELL Heery Christopher (CHIEF MEDICAL OFFICER)

7,437 shares @ $65.51

$487K

Jan 13, 2026

Conviction: | View SEC Filing →
SELL Heery Christopher (CHIEF MEDICAL OFFICER)

6,131 shares @ $64.15

$393K

Jan 12, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.